The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we can back negate most of those risks by giving her aggressive hormone therapy early so she came in to make sure she was on the right dose because in premature ovarian failure we don't want to give them menopause hormone therapy doses they're too low we want to get her more like she would have which is three to four times the amount of estrogen as a reproductive aged woman
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
And what's so interesting is that we'll use premature ovarian failure. So going into ovarian failure before age 40, well accepted that these women need hormone replacement even when they still have the low end of hormonal function.